Luisa Heidemann

Luisa Heidemann is a visiting undergraduate in the Yale Interventional Oncology (IO) Research Lab and a medical student at Charité – Universitätsmedizin Berlin, Germany. As a core member of the Minimally Invasive Tumor Therapies Lab at Charité, she focuses on the locoregional effects following transarterial chemoembolization (TACE) in the context of hepatocellular carcinoma (HCC). At the renowned annual meeting of the Radiological Society of North America in 2024 in Chicago, USA, she presented preliminary results and received a travel grant from the Rolf W. Günther Foundation for Radiological Research.

In the Yale IO Lab, she utilizes her previously acquired methodology to quantify longitudinal immune cell infiltration induced by drug-eluting bead TACE in human HCC samples.